SANOFI-AVENTIS (EPA:SAN) FDA approves Libtayo® (cemiplimab-rwlc) monotherapy for patients with first-line advanced non-small cell lung cancer with PD-L1 expression of =50%

Transparency directive : regulatory news

22/02/2021 19:00


Other stories

02/03/2021 22:52
02/03/2021 23:03
02/03/2021 18:50
03/03/2021 00:19
02/03/2021 23:14
03/03/2021 01:21
02/03/2021 23:00
03/03/2021 01:00
01/03/2021 09:48
02/03/2021 15:00
02/03/2021 23:18
03/03/2021 00:06
02/03/2021 19:53
02/03/2021 23:49
02/03/2021 11:10
02/03/2021 16:01
02/03/2021 20:58
02/03/2021 22:14
02/03/2021 17:56
02/03/2021 21:04
02/03/2021 08:59
02/03/2021 19:30
02/03/2021 20:00
03/03/2021 02:33
02/03/2021 21:11
03/03/2021 00:55
03/03/2021 01:22
02/03/2021 13:24
02/03/2021 23:00
02/03/2021 22:38
02/03/2021 13:25
01/03/2021 23:01
01/03/2021 17:31
02/03/2021 09:36
02/03/2021 19:28
02/03/2021 15:59
02/03/2021 07:00
02/03/2021 11:14